Who Owns EVAX?

Evaxion Biotech A/S — Institutional Ownership & 13F Holdings

$4.10

+0.07 (+1.74%)

Market Cap

$19.5M

Shares Outstanding

6,316,572

Institutional Holders

9

Total Inst. Value

$5.1M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GAMMA Investing LLC$4.9M9,002
2Ikarian Capital, LLC$148K80,000
3BOOTHBAY FUND MANAGEMENT, LLC$44K23,728
4XTX Topco Ltd$30K16,281
5UBS Group AG$12K6,517
6SBI Securities Co., Ltd.$5K2,464
7RHUMBLINE ADVISERS$4K2,208
8Beacon Capital Management, LLC$2K972
9OSAIC HOLDINGS, INC.$4625

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
SBI Securities Co., Ltd.+2K$5K

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold EVAX?

As of Q1 2025, 9 institutional investors report holding EVAX (Evaxion Biotech A/S) in their 13F filings.

Which hedge fund owns the most EVAX?

The largest institutional holder of EVAX is GAMMA Investing LLC with $4.9M in shares.

Are institutions buying or selling EVAX?

This quarter, 8 institutions opened new positions in EVAX and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.